NL Industries director granted 6,000-share stock award

Q: Was the NL director’s Form 4 transaction a stock purchase or a grant?

The Form 4 shows a grant/award acquisition, not an open-market purchase. The 6,000 NL Industries shares were issued for no cash consideration to Dr. Turner under the 2023 Non-Employee Director Stock Plan as part of his director compensation.

NL Industries director Dr. R. Gerald Turner received a stock award of 6,000 common shares on May 14, 2026.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

NL Industries director Dr. R. Gerald Turner received a stock award of 6,000 common shares on May 14, 2026. The shares were issued for no cash consideration under the NL Industries, Inc. 2023 Non-Employee Director Stock Plan, reflecting routine equity-based compensation for board service.

Each share was valued at $6.67 for reporting purposes, and following this grant Dr. Turner directly holds 9,739 NL Industries common shares. This filing records a compensation-related acquisition rather than an open-market purchase or sale.

Insider Trade Summary

Grant/Award: 6,000 shares

Grant/Award 1 txn

Insider TURNER R GERALD DR

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock $0.125 par value per share	6,000	$6.67	$40K

Holdings After Transaction: Common Stock $0.125 par value per share — 9,739 shares (Direct)

Footnotes (1)

F1. Shares issued for no cash consideration to directors under the NL Industries, Inc. 2023 Non-Employee Director Stock Plan.

Key Figures

Shares granted: 6,000 shares Grant value per share: $6.67 per share Shares owned after grant: 9,739 shares +1 more

4 metrics

Shares granted 6,000 shares Common Stock grant on May 14, 2026

Grant value per share $6.67 per share Reporting value for the 6,000-share award

Shares owned after grant 9,739 shares Total direct holdings following the transaction

Par value $0.125 per share Par value of NL Industries common stock

Key Terms

Grant, award, or other acquisition, NL Industries, Inc. 2023 Non-Employee Director Stock Plan, Common Stock $0.125 par value per share, Form 4

4 terms

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

NL Industries, Inc. 2023 Non-Employee Director Stock Plan financial

"Shares issued for no cash consideration to directors under the NL Industries, Inc. 2023 Non-Employee Director Stock Plan."

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did NL (NL Industries Inc) report for Dr. R. Gerald Turner?

NL Industries reported that director Dr. R. Gerald Turner received 6,000 shares of common stock as an equity award. The shares were granted for no cash consideration under the 2023 Non-Employee Director Stock Plan as routine director compensation.

Was the NL director’s Form 4 transaction a stock purchase or a grant?

The Form 4 shows a grant/award acquisition, not an open-market purchase. The 6,000 NL Industries shares were issued for no cash consideration to Dr. Turner under the 2023 Non-Employee Director Stock Plan as part of his director compensation.

At what value were the NL Industries shares granted to Dr. R. Gerald Turner reported?

The 6,000 NL Industries common shares granted to Dr. Turner were reported at $6.67 per share. This value is used for disclosure and accounting purposes and does not indicate a cash purchase in the market.

How many NL Industries shares does Dr. R. Gerald Turner hold after this Form 4 transaction?

After receiving the 6,000-share grant, Dr. R. Gerald Turner directly holds 9,739 NL Industries common shares. This total includes the newly granted shares and reflects his direct ownership position following the reported transaction.

What is the NL Industries 2023 Non-Employee Director Stock Plan mentioned in the Form 4?

The NL Industries 2023 Non-Employee Director Stock Plan is the program under which non-employee directors receive equity awards. In this filing, 6,000 common shares were issued to Dr. Turner for no cash consideration as part of his director compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 05/15/2026 - 08:09 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TURNER R GERALD DR

(Last)

(First)

(Middle)

5430 LBJ FREEWAY, SUITE 1700

(Street)

DALLAS

TEXAS

75240

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NL INDUSTRIES INC [ NL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock $0.125 par value per share	05/14/2026		A⁽¹⁾		6,000	A	$6.67⁽¹⁾	9,739	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Shares issued for no cash consideration to directors under the NL Industries, Inc. 2023 Non-Employee Director Stock Plan.

	Jane R. Grimm, Attorney-in-fact, for Dr. R. Gerald Turner	05/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR